Archive of all publications and media news
Press Release
CRC
Official Press Release Numerous Novel Cancer Targets Discovered for First-in-Class Therapeutics
Article
CRC
Editorial Biology Direct volume 20, Article number: 14 (2025) New hope for the World Cancer Day
Paper
BMC Biology Direct | Melino, G. et al. New hope for the world cancer day
Paper
Prostate
BMC Biology Direct | Scimeca, M. et al. Unveiling the molecular profile of a prostate carcinoma
Article
European Biotechnology Magazine Precision Oncology starts with Precision Insights
Article
Why the first 10 minutes matter in precision oncology
Article
Tissue Is the Issue for Novel Cancer Drug Discovery
Poster
PDF (318.61 kB)
BioTechX Europe | Beck et al. Survival analysis for active modules using learned representations
PDF (318.61 kB)
Article
Advancing Cancer Drug Discovery with a Data-Driven Approach
Article
Roundtable: An exchange on biotechnology in northern Germany
Paper
nature CDD | Von der Heyde, S. et al. Tumor specimen cold ischemia time impacts molecular cancer drug target discovery
Press Release
Study reveals a path for the discovery of new targets and development of novel cancer therapies
Article
IRBLleida and Indivumed extend their collaboration agreement for high-quality biospecimen collection supporting precision oncology research
Poster
PDF (1.9 MB)
ESMO 2024 | Nale et al. Pan-Cancer, Multi-Omic Analysis of 'Hot' and 'Cold' Tumors Reveals Immunotherapy Relevant Signatures
PDF (1.9 MB)
Paper
CRC
Gastroenterology | Ambeskovic, A. et al. Exon Skipping-based Subtyping of Colorectal Cancers
Article
Article in "transkript": 10 minutes make all the difference
Paper
Breast
BMC Biology Direct | Giovannini, S. et al. A comprehensive molecular characterization of a claudin-low luminal B breast tumor
Article
Interview in "BioTechnologie Kursbuch No. 37"
Article
The untapped power of multivariate analysis for target identification in cancer drug discovery - a LaBiotech Article
Paper
Urinary Bladder
nature CDD | Scimeca, M. et. al. Molecular profiling of a bladder cancer with very high tumour mutational burden
Article
Indivumed Omics Hub and Clinical Network Collaborations Powering Precision Medicine Research Publications
Poster
CRC
PDF (1.56 MB)
Poster AACR 2024 | Bischof et al. Deciphering chromosomal instability in consensus molecular Subtypes (CMS) in CRC
PDF (1.56 MB)
Paper
Kidney
Discover Oncology | Scimeca, M. et al. Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma
Interview
1:21 min
In Focus: Clinical Network Interview with Nina Gabelia (MB, MPH)
1:21 min
Interview
1:29 min
In Focus: Onco AI-Med Interview with Dr. John Marshall, Chairman Onco AI-Med Advisory Board
1:29 min
Interview
1:55 min
Onco AI-Med Board Meeting Summary – Interviews with Dr. John Marshall, Prof. David Gallagher & Dr. Sun Young Rha
1:55 min
Interview
1:21 min
Onco AI-Med Board Meeting Summary – Interviews with Dr. John Marshall, Dr. Carlos Sampaio & Dr. David Kerr
1:21 min
Event
AACR | April 25-30, 2025 | Chicago, IL, USA
Event
Bio International Convention | June 16-19, 2025 | Boston, MA, USA
Paper
Liver
Discover Oncology | Mengting Zhu et al. Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype
Article
Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg
Article
Feature in BIO Deutschland Yearbook 2023/2024
Poster
NSCLC
PDF (3.54 MB)
ESMO 2023 | Poster Bischof et al. Combining cancer patient spatial transcriptomics and bulk rna-seq data to drive insights into NSCLC
PDF (3.54 MB)
Paper
Breast
nature CDD | Yuyi, H. et al. A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Paper
Cell Death Discovery 9, 365 (2023) Yang, X. et al: A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency
Article
Precision therapeutics: optimizing early discovery
Paper
PDF (2.24 MB)
MDPI | Michalska-Falkowska et al. Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
PDF (2.24 MB)
Article
Where the medicine of the future is already being lived in the present
Article
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
Article
Optimizing early discovery by unraveling cancer complexity within precision therapeutics
Press Release
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
Press Release
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
Article
Ending the year - Today. Tomorrow. Together.
Press Release
European Union-Funded Project to Result in Novel Treatment Approaches for Several Solid Tumor Types
Article
Indivumed expands its certified service provider portfolio of the spatial transcriptomics technology
Press Release
Indivumed Celebrates 20th Anniversary, Success in Individualized Drug Development
Press Release
Accelerated drug development and personalised treatments for cancer
Article
Indivumed appoints Dr. Stephan Schüller as CFO
Press Release
Northwell and Indivumed reach biobank milestone
Press Release
Indivumed and Biognosys Extend Strategic Partnership
Poster
CRC
PDF (2.93 MB)
AACR 2021 | Marshall et al. Multi-omics characterization markers of left and right-sided colorectal cancer
PDF (2.93 MB)
Press Release
VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs
Press Release
Indivumed Launches the nRavel™ AI Platform for Cancer Research and Drug Development
Press Release
Indivumed Joins KHR Biotec, Expands Partnership with University Medical Center Mainz
Press Release
Indivumed Expands Digital Pathology Asset and Analysis Capacity to Add New Dimension to the IndivuType Multi-omics Discovery Solution
Press Release
Indivumed Announces Expansion Into Drug Development, Formation of Ix Therapeutics
Article
Indivumed appoints Roald Forsberg as new Chief Business Officer
Article
A retrospective and outlook
Article
Indivumed and Ultivue announce collaborative partnership
Press Release
Indivumed Launches Groundbreaking AI Platform to Leverage Multi-omics Data for Discoveries in Oncology
Press Release
Indivumed Announces Global Expansion of Clinical Network to Grow IndivuType Database
Press Release
Indivumed, Gnosis Expand Partnership to Enhance AI and Machine Learning Capabilities
Article
Statement from Dr. Eric L. Powell, Senior Director, Oncology Research Unit, Pfizer, on the collaboration with Indivumed
Article
First joint webinar of Evotec and Indivumed demonstrates the power of Indivumed’s multi-omics database IndivuType for drug development
Article
Indivumed Global Alliance to Broaden Access to Multi-Omics Algorithms, Precision Medicine Education
Press Release
Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Press Release
Indivumed Launches Global Oncology Alliance For Individualized Medicine ("Onco AI-Med")
Article
Indivumed fights COVID-19
Article
Statement COVID-19 Virus – Information to our customers
Article
Indivumed Biobank plays a meaningful role in the ICGC/TCGA Pan-Cancer Project to Decipher the Cancer Genome
Press Release
Evotec and Indivumed announce second joint Drug Discovery Programme
Press Release
Indivumed Announces Expansion of the IndivuType Global Cancer Database in Italy
Press Release
Indivumed Announces Strategic Partnership with Biognosys
Article
Indivumed is pleased to announce that we are joining the 25th Bio-Europe taking place on November 11-13, 2019 in Hamburg as a Regional Host.
Press Release
Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration
Press Release
Indivumed launches first real multi-omics cancer platform to advance precision oncology
Press Release
Indivumed and Gnosis partner to add artificial intelligence capabilities to Indivumed’s platform for multi-omics cancer research
Press Release
Ingress-health and Indivumed announce an international partnership on real-world evidence studies in oncology
Press Release
Evotec and Indivumed announce strategic drug discovery collaboration on precision medicine for colorectal cancer
Press Release
Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services
Article
Indivumed to attend the AACR Annual Meeting, USA, March 31–April 3,2019
Article
Next In Personalized Medicine: Cancer-Phenotyping
Press Release
Indivumed Announces an International Partnership with IMCB to Establish an Asian-Centric Multiomics Cancer Database for Personalized Oncology
Press Release
Indivumed signs agreement with IMCB to build the first global, multiomics cancer database
Press Release
The Salk Institute and Indivumed Partner to Advance Global Cancer Research
Press Release
Investment Plan for Europe: EIB grants loan of EUR 40m to Indivumed
Article
The Importance of Tissue Quality for Personalized Medicine
Press Release
Indivumed and Helomics partner to unlock the power of cancer biospecimens for drug discovery and development
Press Release
MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research
Press Release
Personalized Cancer Medicine - Indivumed and Intermed to form Strategic Alliance
Article
Mayor Olaf Scholz honors Hamburg as international medical research location
Press Release
Indivumed founder and CEO recognized for contribution to liquid biopsy innovation
Press Release
Indivumed’s cancer database reaches a global scale through partnership with the National Cancer Tissue Biobank (NCTB), Indian Institute of Technology Madras, Chennai, India
Press Release
Indivumed Announces Agreement with Regeneron to Provide Tissue Samples for Oncology Research and Development
Press Release
Northwell Health Partners with Indivumed to Create a Cancer Research Biobank
Press Release
Indivumed joins Blood Profiling Atlas in Cancer (Blood PAC)
Press Release
The Pacific Northwest Research Institute and Indivumed GmbH Announce Strategic Collaboration
Press Release
Indivumed and Definiens Partner to Unlock the Power of Tumor Tissue for Drug Discovery and Development
Press Release
Medical University of Bialystok continues efforts to internationalize with its announcement of a research partnership with German Cancer Biotechnology Company, Indivumed GmbH
Press Release